Guidelines for heart failure management have been published by the American College of Cardiology and the American Heart Association in 2001. These guidelines recommend the use of angiotensin-converting enzyme inhibitors and β blockers to improve the symptoms and prognosis of heart failure. Despite being advocated as the cornerstone of medical management, these agents remain underutilized. Not only are these drugs underutilized, but titration to dosages with proven beneficial effects is lacking. Simply achieving widespread usage of these agents would have a significant impact on heart failure outcomes.

Original languageEnglish
Pages (from-to)499-507
Number of pages9
JournalCurrent Treatment Options in Cardiovascular Medicine
Issue number6
StatePublished - Dec 2004


Dive into the research topics of 'Neurohormonal therapy for congestive heart failure'. Together they form a unique fingerprint.

Cite this